2016 annual financial data
X4 Pharmaceuticals, Inc. 2016 Operating margin
X4 Pharmaceuticals, Inc. 2016 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -24,346,000 USD and net income was -22,975,000 USD.
Operating cash flow was -21,639,000 USD.
Get free X4 Pharmaceuticals, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -24,346,000 USD
- Net income
- -22,975,000 USD
- Operating cash flow
- -21,639,000 USD